The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
Open accessAbstract
Several (Z)-5-arylidene-2,4-thiazolidinediones were synthesized and tested as aldose reductase inhibitors (ARIs). The most active of the N-unsubstituted derivatives (2) exerted the same inhibitory activity of Sorbinil. The introduction of an acetic side chain on N-3 of the thiazolidinedione moiety led to a marked increase in lending inhibitory activity, conducting to the discovery of a very potent ARI (4c), whose activity level (IC50=0.13 microM) was in the same range of Tolrestat. Moreover, the corresponding methyl esters (3), devoid of any acidic functionality, showed appreciable inhibitory activity similar to that of the N-unsubstituted compounds. It was also found that the substitution pattern on the 5-benzylidene moiety markedly influenced the activity of N-unsubstituted 2,4-thiazolidinediones 2, compounds with substituents at the meta position being generally more effective than the para-substituted ones; however, this SAR was not evidenced in acetates 3 and acids 4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S. R., Beck, K. D., Moore, L. B., Kliewer, S. A., & Lehmann, J. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950395a · Cited by 638
Bernard, Testa, M., Meyer, U., & Testa, B. (1964) · Academic Press eBooks · Cited by 609
The role of aldose reductase in the development of diabetic complications
Kador, P. F. (1988) · Medicinal Research Reviews · doi:10.1002/med.2610080302 · Cited by 297
MOMOSE, Y., MEGURO, K., IKEDA, H., HATANAKA, C., OI, S., & SOHDA, T. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.1440 · Cited by 290
Cantello, B. C. C., Cawthorne, M. A., Cottam, G. P., Duff, P. T., Haigh, D., Hindley, R. M., Lister, C. A., Smith, S. A., & Thurlby, P. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a017 · Cited by 267
Urzhumtsev, A., Tête-Favier, F., Mitschler, A., Barbanton, J., Barth, P., Urzhumtseva, L., Biellmann, J.-F., Podjarny, A., & Moras, D. (1997) · Structure · doi:10.1016/s0969-2126(97)00216-5 · Cited by 233
Diabetes Complications: Why Is Glucose Potentially Toxic?
Porte, D., & Schwartz, M. W. (1996) · Science · doi:10.1126/science.272.5262.699 · Cited by 200
Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs?
Pfeifer, M. A., Schumer, M. P., & Gelber, D. A. (1997) · Diabetes · doi:10.2337/diab.46.2.s82 · Cited by 194
SOHDA, T., MIZUNO, K., IMAMIYA, E., SUGIYAMA, Y., FUJITA, T., & KAWAMATSU, Y. (1982) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.30.3580 · Cited by 171
Costantino, L., Rastelli, G., Vianello, P., Cignarella, G., & Barlocco, D. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199901)19:1<3::aid-med2>3.0.co;2-7 · Cited by 159
Self-citationPharmacological approaches to the treatment of diabetic complications
Costantino, L., Rastelli, G., Gamberini, M. C., & Barlocco, D. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.8.1245 · Cited by 77
Self-citationLee, Y. S., Chen, Z., & Kador, P. F. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00139-4 · Cited by 67
Novel Euglycemic and Hypolipidemic Agents. 4. Pyridyl- and Quinolinyl-Containing Thiazolidinediones
Lohray, B. B., Bhushan, V., Reddy, A. S., Rao, P. B., Reddy, N. J., Harikishore, P., Haritha, N., Vikramadityan, R. K., Chakrabarti, R., Rajagopalan, R., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980622j · Cited by 59
Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)
Wolffenbuttel, B. H. R., & van Haeften, T. W. (1995) · Drugs · doi:10.2165/00003495-199550020-00006 · Cited by 44
Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones
Zask, A., Jirkovsky, I., Nowicki, J. W., et al. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00167a022 · Cited by 38
Singh, S. B., Malamas, M. S., Hohman, T. C., Nilakantan, R., Carper, D. A., & Kitchen, D. B. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990168z · Cited by 26
Cited by
4-Thiazolidinones: The advances continue…
Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.017 · Cited by 319
Thiazolidinediones as antidiabetic agents: A critical review
Nanjan, M. J., Mohammed, M., Prashantha Kumar, B. R., & Chandrasekar, M. J. N. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.02.009 · Cited by 316
Mendgen, T., Steuer, C., & Klein, C. D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201243p · Cited by 290
Metadata
- Authors
- Bruno, G., Costantino, L., Curinga, C., Maccari, R., Monforte, F., Nicolò, F., Ottanà, R., & Vigorita, M. G.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 10
- Issue
- 4
- Pages
- 1077-1084
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2073532176
- Cited by
- 252
- References
- 17
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.